LOADING
Comparing Procter & Gamble (PG) and Merck & Company (MRK) across the Consumer Staples and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | PG | MRK |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $343.3B | $307.2B |
| P/E Ratio | 21.7 | 37.1 |
| Forward P/E | 20.9 | 48.8 |
| PEG Ratio | 4.17 | 12.21 |
| EPS | $6.85 | $3.51 |
| Revenue Growth (YoY) | 7.4% | 4.9% |
| Profit Margin | 19.2% | 13.6% |
| Return on Equity | 31.1% | 18.9% |
| Dividend Yield | 2.84% | 2.49% |
| Beta | 0.38 | 0.20 |
| 52-Week High | $164.77 | $135.05 |
| 52-Week Low | $134.62 | $75.02 |
| Volume | -- | -- |
Procter & Gamble is the larger company by market capitalization. Procter & Gamble trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Procter & Gamble offers a higher dividend yield for income investors. Procter & Gamble has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.